logo
logo

Pulse Biosciences Appoints Burke T. Barrett As President and CEO, and Kevin Danahy As Chief Commercial Officer

May 14, 2024about 1 year ago

Position

Chief Commercial Officer

Company

Pulse Biosciences, Inc.

Kevin Danahy
HaywardTherapeuticsMedicalBiotechnologyHealth Care

Description

Pulse Biosciences announced the appointment of Burke T. Barrett as President and Chief Executive Officer, while Kevin Danahy, former President and Chief Executive Officer, has been appointed as the Chief Commercial Officer to lead the pilot launch of the recently FDA cleared CellFX nsPFA Percutaneous Electrode System.

Company Information

Company

Pulse Biosciences, Inc.

Location

3957 POINT EDEN WAY

Hayward, California, United States

About

Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months